Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2023

  1. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 15, pp. 2827-2842

2021

  1. Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

    American Journal of Hematology

  2. Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 13, pp. 1426-1436

2018

  1. Giant-cell tumor of the rib cage extending to the spine: Case report

    Orthopade, Vol. 47, Núm. 5, pp. 437-441

  2. Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation

    Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 11, pp. 2365-2370

2015

  1. Finite element analysis and cadaveric cinematic analysis of fixation options for anteriorly implanted trabecular metal interbody cages

    European Spine Journal, Vol. 24, pp. 918-923